Fairmount Funds Management’s Enliven Therapeutics ELVN Stock Holding History

Fairmount Funds Management’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$72.7M	Sell	1,855,644 -1,855,800	-50%	-$51.4M	5.25%	7
2025 Q4	$57.2M	Hold	3,711,444	–	–	4.35%	10
2025 Q3	$76M	Hold	3,711,444	–	–	6.84%	5
2025 Q2	$74.5M	Buy	3,711,444 +508,646	+16%	+$9.63M	9.65%	3
2025 Q1	$63M	Hold	3,202,798	–	–	9.78%	4
2024 Q4	$72.1M	Hold	3,202,798	–	–	7.16%	6
2024 Q3	$81.8M	Hold	3,202,798	–	–	6.63%	5
2024 Q2	$74.8M	Hold	3,202,798	–	–	8.46%	5
2024 Q1	$56.3M	Buy	3,202,798 +1,071,429	+50%	+$16.4M	6.14%	6
2023 Q4	$29.5M	Hold	2,131,369	–	–	3.12%	9
2023 Q3	$29.1M	Buy	2,131,369 +6,744	+0.3%	+$114K	3.5%	10
2023 Q2	$43.4M	Buy	2,124,625 +199,687	+10%	+$4.04M	6.11%	4
2023 Q1	$42.2M	Buy	1,924,938 +1,767,105	+1,120%	+$35.9M	7.25%	5
2022 Q4	$2.58M	Buy	+157,833	New	+$2.52M	0.41%	16

Other funds holding ELVN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return